Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
Open accessAbstract
Glucose and lipid metabolism are linked to each other in many ways. The most important clinical manifestation of this interaction is diabetic dyslipidemia, characterized by elevated triglycerides, low high density lipoprotein cholesterol (HDL-C), and predominance of small-dense LDL particles. However, in the last decade we have learned that the interaction is much more complex. Hypertriglyceridemia and low HDL-C cannot only be the consequence but also the cause of a disturbed glucose metabolism. Furthermore, it is now well established that statins are associated with a small but significant increase in the risk for new onset diabetes. The underlying mechanisms are not completely understood but modulation of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG CoA)-reductase may play a central role as genetic data indicate that mutations resulting in lower HMG CoA-reductase activity are also associated with obesity, higher glucose concentrations and diabetes. Very interestingly, this statin induced increased risk for new onset type 2 diabetes is not detectable in subjects with familial hypercholesterolemia. Furthermore, patients with familial hypercholesterolemia seem to have a lower risk for type 2 diabetes, a phenomenon which seems to be dose-dependent (the higher the low density lipoprotein cholesterol, the lower the risk). Whether there is also an interaction between lipoprotein(a) and diabetes is still a matter of debate.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Low HDL-C levels are associated with systemic inflammation, for example with cigarette smoking, chronic inflammatory diseases or chronic kidney disease.
“Low HDL-C levels are also associated with systemic inflammation, e.g. with cigarette smoking, chronic inflammatory diseases or chronic kidney disease (Fig. 3) [45, 46].”
From HDL cholesterol: reappraisal of its clinical relevance (2017) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674 · see citing works
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., Darius, H., Lewis, B. S., Ophuis, T. O., Jukema, J. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410489 · Cited by 4,487 · cited 2× · see citing works
“Interestingly, ezetimibe (at least in addition to statins) and proprotein convertase subtilisin/kexin type 9 (PCSK9) antibodies do not seem to have an impact on glucose metabolism [9,32,33].”
BackgroundRosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J. J., Gotto, A. M., Kastelein, J. J. P., Köenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641 · see citing works
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549 · see citing works
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837 · see citing works
Nordestgaard, B. G., Chapman, M. J., Humphries, S. E., Ginsberg, H. N., Masana, L., Descamps, O. S., Wiklund, O., Hegele, R. A., Raal, F. J., Defesche, J. C., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht273 · Cited by 2,761 · see citing works
Self-citationStatins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
Sattar, N., Preiss, D., Murray, H. M., Welsh, P., Buckley, B. M., de Craen, A. J., Seshasai, S. R. K., McMurray, J. J., Freeman, D. J., Jukema, J. W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61965-6 · Cited by 2,436 · see citing works
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Robinson, J. G., Farnier, M., Krempf, M., Bergeron, J., Luc, G., Averna, M., Stroes, E. S., Langslet, G., Raal, F. J., El Shahawy, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501031 · Cited by 2,296 · see citing works
Collaborators, C. T. T. (. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60104-x · Cited by 2,081 · see citing works
(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753 · see citing works
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
Sabatine, M. S., Giugliano, R. P., Wiviott, S. D., Raal, F. J., Blom, D. J., Robinson, J., Ballantyne, C. M., Somaratne, R., Legg, J., Wasserman, S. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500858 · Cited by 1,509 · see citing works
Preiss, D. (2011) · JAMA · doi:10.1001/jama.2011.860 · Cited by 1,390 · see citing works
Cuchel, M., Bruckert, E., Ginsberg, H. N., Raal, F. J., Santos, R. D., Hegele, R. A., Kuivenhoven, J. A., Nordestgaard, B. G., Descamps, O. S., Steinhagen-Thiessen, E., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu274 · Cited by 1,057 · see citing works
Self-citationn–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
Kromhout, D., Giltay, E. J., & Geleijnse, J. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003603 · Cited by 936 · see citing works
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
Jun, M., Foote, C., Lv, J., Neal, B., Patel, A., Nicholls, S. J., Grobbee, D. E., Cass, A., Chalmers, J., & Perkovic, V. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60656-3 · Cited by 933 · see citing works
n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203859 · Cited by 929 · see citing works
Metabolic origins and clinical significance of LDL heterogeneity
Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896 · see citing works
Freeman, D. J., Norrie, J., Sattar, N., Neely, R. D. G., Cobbe, S. M., Ford, I., Isles, C., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., et al. (2001) · Circulation · doi:10.1161/01.cir.103.3.357 · Cited by 844 · see citing works
Lee, Y., Hirose, H., Ohneda, M., Johnson, J. H., McGarry, J., & Unger, R. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10878 · Cited by 832 · see citing works
Adiels, M., Olofsson, S.-O., Taskinen, M.-R., & Borén, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.160192 · Cited by 820 · see citing works
Efficacy of statins in familial hypercholesterolaemia: a long term cohort study
Versmissen, J., Oosterveer, D. M., Yazdanpanah, M., Defesche, J. C., Basart, D. C. G., Liem, A. H., Heeringa, J., Witteman, J. C. M., Lansberg, P. J., Kastelein, J. J. P., et al. (2008) · BMJ · doi:10.1136/bmj.a2423 · Cited by 719 · see citing works
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.028 · Cited by 706 · see citing works
Swerdlow, D. I., Preiss, D., Kuchenbaecker, K. B., Holmes, M. V., Engmann, J. E. L., Shah, T., Sofat, R., Stender, S., Johnson, P. C. D., Scott, R. A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61183-1 · Cited by 680 · see citing works
Hegele, R. A., Ginsberg, H. N., Chapman, M. J., Nordestgaard, B. G., Kuivenhoven, J. A., Averna, M., Borén, J., Bruckert, E., Catapano, A. L., Descamps, O. S., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70191-8 · Cited by 635 · see citing works
Self-citationBrown, M. S., & Goldstein, J. L. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.3.788 · Cited by 598 · see citing works
Li-ya, W., & Parhofer, K. G. (2014) · Metabolism · doi:10.1016/j.metabol.2014.08.010 · Cited by 523 · see citing works
Self-citationStatin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative
Culver, A. L. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.625 · Cited by 444 · see citing works
High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus
Drew, B. G., Duffy, S. J., Formosa, M. F., Natoli, A. K., Henstridge, D. C., Penfold, S. A., Thomas, W. G., Mukhamedova, N., de Courten, B., Forbes, J. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.843219 · Cited by 443 · see citing works
Association Between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus
Besseling, J., Kastelein, J. J. P., Defesche, J. C., Hutten, B. A., & Hovingh, G. K. (2015) · JAMA · doi:10.1001/jama.2015.1206 · Cited by 387 · see citing works
Raal, F. J., Pilcher, G. J., Panz, V. R., van Deventer, H. E., Brice, B. C., Blom, D. J., & Marais, A. D. (2011) · Circulation · doi:10.1161/circulationaha.111.042523 · Cited by 366 · see citing works
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
Sabatine, M. S., Giugliano, R. P., & Wiviott, S. D. (2015) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2015.08.004 · Cited by 360 · see citing works
Lipid and lipoprotein dysregulation in insulin resistant states
Avramoglu, R. K., Basciano, H., & Adeli, K. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.12.026 · Cited by 318 · see citing works
Briaud, I., Harmon, J. S., Kelpe, C. L., Segu, V. B. G., & Poitout, V. (2001) · Diabetes · doi:10.2337/diabetes.50.2.315 · Cited by 317 · see citing works
Cederberg, H., Stančáková, A., Yaluri, N., Modi, S. R., Kuusisto, J., & Laakso, M. (2015) · Diabetologia · doi:10.1007/s00125-015-3528-5 · Cited by 316 · see citing works
The emerging role of HDL in glucose metabolism
Drew, B. G., Rye, K.-A., Duffy, S. J., Barter, P., & Kingwell, B. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.235 · Cited by 307 · see citing works
Proatherogenic Role of Elevated CE Transfer From HDL to VLDL 1 and Dense LDL in Type 2 Diabetes
Guérin, M., Goff, W. L., Lassel, T. S., van Tol, A., Steiner, G. A., & Chapman, M. J. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.2.282 · Cited by 258 · see citing works
Lipoprotein(a) and Risk of Type 2 Diabetes
Mora, S., Kamstrup, P. R., Rifai, N., Nordestgaard, B. G., Buring, J. E., & Ridker, P. M. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.146779 · Cited by 240 · see citing works
Barter, P. J., Rye, K., Tardif, J., Waters, D. D., Boekholdt, S. M., Breazna, A., & Kastelein, J. J. P. (2011) · Circulation · doi:10.1161/circulationaha.111.018259 · Cited by 198 · see citing works
Duez, H., Lamarche, B., Uffelman, K. D., Valéro, R., Cohn, J. S., & Lewis, G. F. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000222015.76038.14 · Cited by 188 · see citing works
Ten-Year Follow-up After Initiation of Statin Therapy in Children With Familial Hypercholesterolemia
Kusters, D. M., Avis, H. J., de Groot, E., Wijburg, F. A., Kastelein, J. J. P., Wiegman, A., & Hutten, B. A. (2014) · JAMA · doi:10.1001/jama.2014.8892 · Cited by 176 · see citing works
Free Fatty Acids and Skeletal Muscle Insulin Resistance
Rachek, L. I. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00008-9 · Cited by 139 · see citing works
Umans-Eckenhausen, M. A. W., Sijbrands, E. J. G., Kastelein, J. J. P., & Defesche, J. C. (2002) · Circulation · doi:10.1161/01.cir.0000041253.61683.08 · Cited by 100 · see citing works
Lehti, M., Donelan, E. M., Abplanalp, W., Al-Massadi, O., Habegger, K., Weber, J., Ress, C., Mansfeld, J., Somvanshi, S., Trivedi, C. J., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001551 · Cited by 84 · see citing works
Effect of Atorvastatin (10 mg/day) on Glucose Metabolism in Patients With the Metabolic Syndrome
Huptas, S., Geiss, H. C., Otto, C., & Parhofer, K. G. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.01.055 · Cited by 80 · see citing works
Self-citationVohl, M., Gaudet, D., Moorjani, S., Tremblay, G., Perron, P., Gagné, C., Lesiège, D., Bergeron, J., Lupien, P. J., & Després, J. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.1250669.x · Cited by 62 · see citing works
Cai, R., Yuan, Y., Zhou, Y., Xia, W., Wang, P., Sun, H., Yang, Y., Huang, R., & Wang, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104922 · Cited by 53 · see citing works
Skoumas, J., Liontou, C., Chrysohoou, C. A., Masoura, C., Aznaouridis, K. A., Pitsavos, C., & Stefanadis, C. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.08.047 · Cited by 42 · see citing works
Lipids and lipoprotein(a) concentrations in Pakistani patients with type 2 diabetes mellitus
Habib, S. S., & Aslam, M. N. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1462-8902.2004.00352.x · Cited by 29 · see citing works
Lipoprotein(a) is not related to markers of insulin resistance in pregnancy
Todoric, J., Handisurya, A., Leitner, K., Harreiter, J., Hoermann, G., & Kautzky‐Willer, A. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-138 · Cited by 22 · see citing works
Statins and new‐onset diabetes mellitus – a risk lacking in familial hypercholesterolaemia
Vuorio, A. F., Strandberg, T. E., Schneider, W. J., & Kovanen, P. T. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12405 · Cited by 12 · see citing works
Mortensen, S. P., & Boushel, R. (2013) · Circulation · doi:10.1161/circulationaha.113.006345 · Cited by 9 · see citing works
Flagged first, then by citations
1 of the 52 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Clinical Update: Cardiovascular Disease in Diabetes Mellitus
Wang, C. C. L., Hess, C. N., Hiatt, W. R., & Goldfine, A. B. (2016) · Circulation · doi:10.1161/circulationaha.116.022194 · Cited by 1,183 · see citing works
Azzu, V., Vacca, M., Virtue, S., Allison, M., & Vidal-Puig, A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.054 · Cited by 369 · see citing works
Early detection of type 2 diabetes mellitus using machine learning-based prediction models
Kopitar, L., Kocbek, P., Cilar, L., Sheikh, A., & Stiglic, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-68771-z · Cited by 369 · see citing works
HDL cholesterol: reappraisal of its clinical relevance
März, W., Kleber, M. E., Scharnagl, H., Speer, T., Zewinger, S., Ritsch, A., Parhofer, K. G., von Eckardstein, A., Landmesser, U., & Laufs, U. (2017) · Clinical Research in Cardiology · doi:10.1007/s00392-017-1106-1 · Cited by 275 · see citing works
Self-citationAging Hallmarks and Progression and Age-Related Diseases: A Landscape View of Research Advancement
Tenchov, R., Sasso, J. M., Wang, X., & Zhou, Q. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00531 · Cited by 276 · see citing works
iNOS as a metabolic enzyme under stress conditions
Anavi, S., & Tirosh, O. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.10.411 · Cited by 226 · see citing works
Lee, E. Y., Yang, H. K., Lee, J., Kang, B., Yang, Y., Lee, S., Ko, S., Ahn, Y., Cha, B. Y., Yoon, K., et al. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0324-2 · Cited by 221 · see citing works
Walaszczyk, E., Luijten, M., Spijkerman, A., Bonder, M., Lutgers, H., Snieder, H., Wolffenbuttel, B., & van Vliet-Ostaptchouk, J. V. (2017) · Diabetologia · doi:10.1007/s00125-017-4497-7 · Cited by 123 · see citing works
Beyene, H. B., Olshansky, G., Smith, A., Giles, C., Huynh, K., Cinel, M. A., Mellett, N. A., Cadby, G., Hung, J., Hui, J., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000870 · Cited by 161 · see citing works
Mamo, Y., Bekele, F., Nigussie, T., & Zewudie, A. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0421-0 · Cited by 147 · see citing works
van Stee, M. F., de Graaf, A. A., & Groen, A. K. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0738-4 · Cited by 147 · see citing works
Mechanisms and Treatment of Dyslipidemia in Diabetes
Bahiru, E. M., Hsiao, R., Philipson, D. J., & Watson, K. E. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01455-w · Cited by 145 · see citing works
The Role of Lipids in the Regulation of Immune Responses
Garcia, C., Andersen, C. J., & Blesso, C. N. (2023) · Nutrients · doi:10.3390/nu15183899 · Cited by 141 · see citing works
Dietary stearic acid regulates mitochondria in vivo in humans
Senyilmaz, D., Pfaff, D. H., Virtue, S., Schwarz, K. V., Fleming, T., Altamura, S., Muckenthaler, M. U., Okun, J. G., Vidal‐Puig, A., Nawroth, P. P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05614-6 · Cited by 132 · see citing works
The evolution of domain arrangements in proteins and interaction networks
Bornberg‐Bauer, E., Beaussart, F., Kummerfeld, S., Teichmann, S. A., & Weiner, J. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4416-1 · Cited by 124 · see citing works
Particulate matter air pollutants and cardiovascular disease: Strategies for intervention
Aryal, A., Harmon, A. C., & Dugas, T. R. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107890 · Cited by 116 · see citing works
Hu, J., Gillies, C. L., Lin, S., Stewart, Z. A., Melford, S. E., Abrams, K. R., Baker, P. N., Khunti, K. K., & Tan, B. K. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100830 · Cited by 103 · see citing works
Singh, B., Kumar, A., Singh, H. B., Kaur, S., Arora, S., & Singh, B. (2022) · Phytotherapy Research · doi:10.1002/ptr.7392 · Cited by 88 · see citing works
Grabež, M., Škrbić, R., Stojiljković, M. P., Rudić-Grujić, V., Paunović, M., Arsić, A., Petrović, S., Vučić, V., Mirjanić-Azarić, B., Šavikin, K., et al. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103692 · Cited by 85 · see citing works
Liu, Y., Liu, S., Huang, J., Liu, Y., Wang, Q., Chen, J., Sun, L., & Tu, W. (2023) · Environment International · doi:10.1016/j.envint.2023.107977 · Cited by 83 · see citing works
Mazidi, M., Valdes, A. M., Ordovás, J. M., Hall, W. L., Pujol, J. C., Wolf, J., Hadjigeorgiou, G. M., Segata, N., Sattar, N. A., Koivula, R. W., et al. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab132 · Cited by 79 · see citing works
Indole-3-Propionic Acid, a Gut-Derived Tryptophan Metabolite, Associates with Hepatic Fibrosis
Sehgal, R., Ilha, M., Vaittinen, M., Kamińska, D., Männistö, V., Kärjä, V. J., Tuomainen, M. H., Hanhineva, K., Romeo, S., Pajukanta, P., et al. (2021) · Nutrients · doi:10.3390/nu13103509 · Cited by 77 · see citing works
Cardiovascular organ damage in type 2 diabetes mellitus: the role of lipids and inflammation
Kozàkovà, M., Morizzo, C., Gonçalves, I., Natali, A., Nilsson, J. Å., & Palombo, C. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0865-6 · Cited by 75 · see citing works
Luo, M., Lim, W. Y., Tan, C. S., Ning, Y., Chia, K. S., van Dam, R. M., Tang, W. E., Tan, N. C., Chen, R., Tai, E. S., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.08.013 · Cited by 73 · see citing works
Poolsup, N., Suksomboon, N., Kurnianta, P. D. M., & Deawjaroen, K. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215840 · Cited by 73 · see citing works
RetractedThe roles of dietary lipids and lipidomics in gut-brain axis in type 2 diabetes mellitus
Ağagündüz, D., İçer, M. A., Yeşildemir, Ö., Koçak, T., Koçyiğit, E., & Capasso, R. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04088-5 · Cited by 72 · see citing works
Grabež, M., Škrbić, R., Stojiljković, M. P., Vučić, V., Grujić, V. R., Jakovljevic, V. L., Djuric, D. M., Suručić, R. V., Šavikin, K., Bigović, D., et al. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2302057 · Cited by 71 · see citing works
Babiker, R. A., Elmusharaf, K., Keogh, M. B., & Saeed, A. M. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0711-y · Cited by 69 · see citing works
TyG index a promising biomarker for glycemic control in type 2 Diabetes Mellitus
Hameed, E. K. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.11.030 · Cited by 68 · see citing works
Triglycerides and glucose index as an insulin resistance marker in a sample of healthy adults
Toro-Huamanchumo, C. J., Urrunaga‐Pastor, D., Guarnizo-Poma, M., Lázaro-Alcántara, H., Paico-Palacios, S., Pantoja-Torres, B., Ranilla-Seguin, V. D. C., & Benites-Zapata, V. A. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.09.010 · Cited by 67 · see citing works
HDL-Cholesterol, Its Variability, and the Risk of Diabetes: A Nationwide Population-Based Study
Lee, S., Kim, H., Park, Y., Kwon, H., Yoon, K., Han, K., & Kim, M. K. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01080 · Cited by 66 · see citing works
Glucose and Lipid Dysmetabolism in a Rat Model of Prediabetes Induced by a High-Sucrose Diet
Burgeiro, A., Cerqueira, M., Varela-Rodríguez, B. M., Nunes, S., Neto, P., Pereira, F. C., Reis, F., & Carvalho, E. (2017) · Nutrients · doi:10.3390/nu9060638 · Cited by 68 · see citing works
Al-Mhanna, S. B., Franklin, B. A., Jakicic, J. M., Stamatakis, E. A., Pescatello, L. S., Riebe, D. A., Thompson, W. R., Skinner, J. S., Colberg, S. R., Alkhamees, N. H., et al. (2025) · British Journal of Sports Medicine · doi:10.1136/bjsports-2024-108947 · Cited by 66 · see citing works
PKM2‐TMEM33 axis regulates lipid homeostasis in cancer cells by controlling SCAP stability
Liu, F., Ma, M., Gao, A., Ma, F., Ma, G., Liu, P., Jia, C., Wang, Y., Donahue, K., Zhang, S., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108065 · Cited by 63 · see citing works
Kim, J., Lee, H. S., & Lee, K. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0799-4 · Cited by 61 · see citing works
Rosada, A., Kassner, U., Weidemann, F., König, M., Buchmann, N., Steinhagen‐Thiessen, E., & Spira, D. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01277-9 · Cited by 59 · see citing works
Zhai, L., Ning, Z., Huang, T., Wen, B., Liao, C., Lin, C., Zhao, L., Xiao, H., & Bian, Z. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00973 · Cited by 58 · see citing works
A Synthetic-Biology-Inspired Therapeutic Strategy for Targeting and Treating Hepatogenous Diabetes
Xue, S., Yin, J., Shao, J., Yu, Y., Yang, L., Wang, Y., Xie, M., Fussenegger, M., & Ye, H. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.11.008 · Cited by 57 · see citing works
4-Hydroxyisoleucine: A Potential New Treatment for Type 2 Diabetes Mellitus
Zafar, M. I., & Gao, F. (2016) · BioDrugs · doi:10.1007/s40259-016-0177-2 · Cited by 56 · see citing works
Phenolics and anthocyanins in berries of European cranberry and their antimicrobial activity
Česonienė, L., Jasutienė, I., & Šarkinas, A. (2024) · PubMed · doi:10.5281/zenodo.11174808 · Cited by 56 · see citing works
Liver-adipose tissue crosstalk: A key player in the pathogenesis of glucolipid metabolic disease
Ye, D.-W., Rong, X., Xu, A., & Guo, J. (2017) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-017-2810-4 · Cited by 55 · see citing works
Lee, Y.-C., Lee, J., & Kwon, Y. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221122671 · Cited by 53 · see citing works
Luo, Y., Qu, H., Wang, H., Wei, H., Wu, J., Duan, Y., Liu, D., & Deng, H. (2016) · Mediators of Inflammation · doi:10.1155/2016/6423637 · Cited by 53 · see citing works
Cheng, Z., Qiao, D., Zhao, S., Zhang, B., Lin, Q., & Xie, F. (2022) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12985 · Cited by 52 · see citing works
Chen, Y., Chang, Z., Zhao, Y., Liu, Y., Fu, J., Zhang, Y., Liu, Y., & Fan, Z. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.04.010 · Cited by 49 · see citing works
Correlation between Glycated Hemoglobin and Triglyceride Level in Type 2 Diabetes Mellitus
Naqvi, S., Naveed, S., Ali, Z., Ahmad, S. M., Khan, R. A., Raj, H., Shariff, S., Rupareliya, C., Zahra, F., & Khan, S. (2017) · Cureus · doi:10.7759/cureus.1347 · Cited by 49 · see citing works
Daidzein mitigates myocardial injury in streptozotocin-induced diabetes in rats
Laddha, A. P., & Kulkarni, Y. A. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119664 · Cited by 49 · see citing works
Hibiscus sabdariffa in Diabetes Prevention and Treatment—Does It Work? An Evidence-Based Review
Jamrozik, D., Borymska, W., & Kaczmarczyk-Żebrowska, I. (2022) · Foods · doi:10.3390/foods11142134 · Cited by 47 · see citing works
Bioactive Compounds from Cardoon as Health Promoters in Metabolic Disorders
Silva, L. R., Jacinto, T. A., & Coutinho, P. (2022) · Foods · doi:10.3390/foods11030336 · Cited by 48 · see citing works
Yalçınkaya, M., Kerksiek, A., Gebert, K., Annema, W., Sibler, R., Radosavljevic, S., Lütjohann, D., Rohrer, L., & von Eckardstein, A. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000509 · Cited by 45 · see citing works
Neta, J. F. D. F., Veras, V. S., de Sousa, D. F., Cunha, M. D. C. D. S. O., Queiroz, M. V. O., Neto, J. C. G. L., Damasceno, M. M. C., de Araújo, M. F. M., & de Freitas, R. W. J. F. (2021) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2021.1885015 · Cited by 45 · see citing works
Role of ferroptosis in pregnancy related diseases and its therapeutic potential
Xu, J., Zhou, F., Wang, X., & Mo, C. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1083838 · Cited by 45 · see citing works
Piccirillo, F., Mastroberardino, S., Nusca, A., Frau, L., Guarino, L., Napoli, N., Ussia, G. P., & Grigioni, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210164 · Cited by 44 · see citing works
Mahmoud, I., & Sulaiman, N. D. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031969 · Cited by 44 · see citing works
Effect of short-chain chlorinated paraffins on metabolic profiling of male SD rats
Geng, N., Luo, Y., Cao, R., Song, X., Li, F., Wang, F., Gong, Y., Xing, L., Zhang, H., & Chen, J. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.141404 · Cited by 43 · see citing works
Zarezadeh, M., Musazadeh, V., Faghfouri, A. H., Sarmadi, B., Jamilian, P., Jamilian, P., Tutunchi, H., & Dehghan, P. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106397 · Cited by 43 · see citing works
Shaw, E., Talwadekar, M., Rashida, Z., Mohan, N., Acharya, A., Khatri, S., Laxman, S., & Kolthur‐Seetharam, U. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00212-19 · Cited by 42 · see citing works
Kumar, A., Satheesh, G., Vijayakumar, G., Chandran, M., Prabhu, P. R., Simon, L., Kutty, V. R., Kartha, C. S., & Jaleel, A. (2020) · Scientific Reports · doi:10.1038/s41598-019-57257-2 · Cited by 41 · see citing works
Baydar, O., Kılıç, A., Okcuoglu, J., Apaydın, Z., & Can, M. M. (2021) · Angiology · doi:10.1177/00033197211007719 · Cited by 43 · see citing works
Soremekun, O. S., Karhunen, V., He, Y., Rajasundaram, S., Liu, B., Gkatzionis, A., Soremekun, C., Udosen, B., Musa, H. S., Silva, S., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103953 · Cited by 43 · see citing works
Inflammation: Is It a Healer, Confounder, or a Promoter of Cardiometabolic Risks?
Tate, A. R., & Rao, G. H. R. (2024) · Biomolecules · doi:10.3390/biom14080948 · Cited by 42 · see citing works
Astaxanthin as a metabolic regulator of glucose and lipid homeostasis
Medoro, A., Intrieri, M., Passarella, D., Willcox, D. C., Davinelli, S., & Scapagnini, G. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105937 · Cited by 42 · see citing works
Xiao, Q., Li, X., Duan, B., Li, X., Liu, S., Xu, B., Shi, S., Zhang, J., Qin, H., Duan, X., et al. (2022) · Scientific Reports · doi:10.1038/s41598-021-04128-4 · Cited by 41 · see citing works
Shi, K., Hou, J., Zhang, Q., Bi, Y., Zeng, X., & Wang, X. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1127913 · Cited by 41 · see citing works
Erukainure, O. L., Oyebode, O. A., Ijomone, O. M., Chukwuma, C. I., Koorbanally, N. A., & Islam, M. S. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.03.039 · Cited by 41 · see citing works
Ginsenoside Rg5 relieves type 2 diabetes by improving hepatic insulin resistance in db/db mice
Wei, Y., Yang, H., Zhu, C., Deng, J., & Fan, D. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104014 · Cited by 41 · see citing works
Pérez-Fernández, C., Morales‐Navas, M., Aguilera-Sáez, L. M., Abreu, A. C., Guardia-Escote, L., Fernández, I., Garrido-Cárdenas, J. A., Colomina, M. T., Giménez, E., & Sánchez-Santed, F. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109341 · Cited by 40 · see citing works
Implications of vitamin D deficiency in systemic inflammation and cardiovascular health
Dey, S. K., Kumar, S., Rani, D., Maurya, S. K., Banerjee, P., Verma, M., & Senapati, S. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2224880 · Cited by 41 · see citing works
Kheiripour, N., Karimi, J., Khodadadi, I., Tavilani, H., Goodarzi, M. T., & Hashemnia, M. (2018) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2017-0122 · Cited by 39 · see citing works
Loef, B., van Baarle, D., van der Beek, A. J., Beekhof, P., van Kerkhof, L. W., & Proper, K. I. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211557 · Cited by 39 · see citing works
Namkhah, Z., Ashtary‐Larky, D., Naeini, F., Clark, C. C. T., & Asbaghi, O. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105665 · Cited by 39 · see citing works
Nayak, V. K. R., Nayak, K. R., Vidyasagar, S., & Kamath, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200775 · Cited by 38 · see citing works
The PDK1 Inhibitor Dichloroacetate Controls Cholesterol Homeostasis Through the ERK5/MEF2 Pathway
Khan, A. U. H., Allende-Vega, N., Gitenay, D., Gerbal‐Chaloin, S., Gondeau, C., Vo, D.-N., Belkahla, S., Orecchioni, S., Talarico, G., Bertolini, F., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10339-5 · Cited by 37 · see citing works
Achila, O. O., Ghebretinsae, M., Kidane, A., Simon, M., Makonen, S., & Rezene, Y. (2020) · Journal of Diabetes Research · doi:10.1155/2020/5901569 · Cited by 34 · see citing works
“Multiple pathophysiological processes underlying these complications have been proposed [6].”
BackgroundAcharya, P., & Talahalli, R. R. (2018) · Inflammation · doi:10.1007/s10753-018-0949-6 · Cited by 36 · see citing works
Zhai, L., Huang, T., Xiao, H., Wu, P., Lin, C., Ning, Z., Zhao, L., Kwan, H. Y., Hu, X., Wong, H. L. X., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.576496 · Cited by 36 · see citing works
Chen, L., Mir, S. A., Bendt, A. K., Chua, E. W. L., Narasimhan, K., Tan, K. M. L., Loy, S. L., Tan, K. H., Shek, L. P., Chan, J. K. Y., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02740-x · Cited by 35 · see citing works
Dyslipidaemia in type 2 diabetes mellitus
Katsiki, N., Tentolouris, N., & Mikhailidis, D. P. (2017) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000407 · Cited by 35 · see citing works
Wang, M.-C., Li, C., Liu, C.-S., Lin, C.-H., Yang, S.-Y., Lin, C., & Lin, C. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01421-4 · Cited by 35 · see citing works
Chen, W., Ding, S., Tu, J., Xiao, G., Chen, K., Zhang, Y., Huang, R., & Liao, Y. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01834-y · Cited by 34 · see citing works
Disha, Z., Yao, Y., Zou, N., & Yu, J. M. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12549 · Cited by 34 · see citing works
Dietary calcium affects body composition and lipid metabolism in rats
Alomaim, H., Griffin, P., Swist, E., Plouffe, L. J., Vandeloo, M., Demonty, I., Kumar, A., & Bertinato, J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210760 · Cited by 34 · see citing works
Roman, M., Kamińska, A., Drożdż, A., Platt, M., Kuźniewski, M., Malecki, M. T., Kwiatek, W. M., Paluszkiewicz, C., & Stępień, E. Ł. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.01.011 · Cited by 34 · see citing works
DO‐SRS imaging of diet regulated metabolic activities in Drosophila during aging processes
Li, Y., Zhang, W., Fung, A. A., & Shi, L. (2022) · Aging Cell · doi:10.1111/acel.13586 · Cited by 34 · see citing works
Characterization of PFOS toxicity on in-vivo and ex-vivo mouse pancreatic islets
Wan, H. T., Cheung, L. Y., Chan, T., Li, M., Lai, K. P., & Wong, C. K. C. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.117857 · Cited by 33 · see citing works
Viktorínová, A., Jurkovičová, I., Fábryová, Ľ., Kiňová, S., Koreň, M., Stecova, A., & Sviteková, K. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.055 · Cited by 32 · see citing works
Association of METS-IR index with depressive symptoms in US adults: A cross-sectional study
Huang, Q. R., Wang, D., Chen, S., Tang, L., & Ma, C. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.03.129 · Cited by 31 · see citing works
Wang, T., Zhang, M., Shi, W., Li, Y., Zhang, T., & Shi, W. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02653-4 · Cited by 30 · see citing works
Rawat, A. K., Misra, G., Saxena, M., Tripathi, S., Dubey, D., Saxena, S., Aggarwal, A., Gupta, V., Khan, M., & Prakash, A. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.09.009 · Cited by 30 · see citing works
Thambiah, S. C., & Lai, L. C. (2021) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2021.e00248 · Cited by 33 · see citing works
Jiang, L., Bao, W., Zhang, T., Zhou, Y., Yang, H., Jia, H., Wang, R., Cao, Y., & Xiao, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0190310 · Cited by 30 · see citing works
Singh, R., Pervin, S., Lee, S., Kuo, A., Grijalva, V. R., David, J., Vergnes, L., & Reddy, S. T. (2018) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s159315 · Cited by 29 · see citing works
Glycemic Control and the Heart: The Tale of Diabetic Cardiomyopathy Continues
Longo, M., Scappaticcio, L., Cirillo, P., Maio, A., Carotenuto, R. M., Maiorino, M. I., Bellastella, G., & Esposito, K. (2022) · Biomolecules · doi:10.3390/biom12020272 · Cited by 29 · see citing works
Salau, V. F., Erukainure, O. L., Olofinsan, K. A., Bharuth, V., Ijomone, O. M., & Islam, M. S. (2022) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12860 · Cited by 29 · see citing works
Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells
Mayengbam, S. S., Singh, A., Yaduvanshi, H., Bhati, F. K., Deshmukh, B., Athavale, D., Ramteke, P. L., & Bhat, M. K. (2023) · Cancer & Metabolism · doi:10.1186/s40170-023-00315-1 · Cited by 28 · see citing works
Jin, H., & Nicodemus‐Johnson, J. (2018) · Nutrients · doi:10.3390/nu10111760 · Cited by 28 · see citing works
Isse, F. A., El-Sherbeni, A. A., & El‐Kadi, A. O. S. (2022) · Drug Metabolism Reviews · doi:10.1080/03602532.2022.2051045 · Cited by 27 · see citing works
Hariharan, R., Cameron, J., Menon, K., Mesinovic, J., Jansons, P., Scott, D. S., Lu, Z. X., de Courten, M., Feehan, J., & de Courten, B. V. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.10.012 · Cited by 28 · see citing works
Cho, H. M., Seok, Y. M., Lee, H. A., Song, M., & Kim, I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113539 · Cited by 27 · see citing works
Roles of microRNAs in carbohydrate and lipid metabolism disorders and their therapeutic potential
Paul, S., Bravo-Vázquez, L. A., Uribe, S. P., Cárdenas, L. A. M., Aguilar, M. F. R., Chakraborty, S., & Sharma, A. K. (2021) · Biochimie · doi:10.1016/j.biochi.2021.05.015 · Cited by 27 · see citing works
- Authors
- Parhofer, K. G.
- Affiliations
- Ludwig-Maximilians-Universität München (DE)
- Corresponding author
- Parhofer, Klaus G.
- ORCID
- Parhofer, Klaus G.
- Venue
- Diabetes & Metabolism Journal
- Publisher
- Korean Diabetes Association
- Published
- 2015
- Volume
- 39
- Issue
- 5
- Pages
- 353
- ISSN
- 2233-6079 (ISSN-L)
- 2233-6087
- PMC
- PMC4641964
- OpenAlex
- W2114340826
- Cited by
- 458
- References
- 52
- Citations by year
- 2026: 29 · 2025: 61 · 2024: 62 · 2023: 58 · 2022: 48 · 2021: 64 · 2020: 37 · 2019: 33 · 2018: 28 · 2017: 21 · 2016: 16
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Diabetes & Metabolism Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- diabetic dyslipidemia, hypertriglyceridemia, low HDL cholesterol, small dense LDL, statin-induced diabetes, HMG-CoA reductase, type 2 diabetes, familial hypercholesterolemia, LDL cholesterol, lipoprotein(a), obesity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review